D-1513-2016 Class II Terminated
FDA drug recall D-1513-2016 was initiated by Sandoz Inc on Aug 24, 2016 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised. The recall status is terminated (terminated Jul 12, 2017). Affected quantity: 32,099 cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 28, 2016
- Initiation Date
- Aug 24, 2016
- Termination Date
- Jul 12, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 32,099 cartons
Product description
Ephedrine Sulfate Injection, USP, 50 mg/mL, 1 mL Fill in a 2mL Vial (NDC 66758-008-01), packaged in 25 x 2 mL Vials per carton (NDC 66758-008-02), Rx only, Manufactured for: Sandoz Inc., Princeton, NJ 08540.
Reason for recall
Lack of Assurance of Sterility: a recent FDA inspection at the manufacturing firm raised concerns that product sterility may be compromised.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: 080514, 080614, 081114, 081214, 081314, 081414, 082714, 082814, 082914, Exp 08/16; 090214, 090314, 090814, 090914, 091014, 091114, 091214, 091514, Exp 09/16
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1513-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026